Showing results (1551-1560 of 1,628) with videos related to

Sort By:
Pageof 163
Molecular Cell|July 12, 2024
Dynamic BTB-domain filaments promote clustering of ZBTB proteinsLucija Mance, Nicolas Bigot, Edison Zhamungui Sánchez, et al.
Blood|July 19, 2015
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibitionNathalie Jacque, Anne Marie Ronchetti, Clément Larrue, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2016
Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter StudyF Robin, R Beyrouthy, S Bonacorsi, et al.
Acta Neuropathologica Communications|January 9, 2022
The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defectsErwan Lambert, Orthis Saha, Bruna Soares Landeira, et al.
Immunity|April 24, 2026
Homeostatic mature dendritic cells instruct fibroblast specialization via Notch2 signaling to establish T cell nichesNagham Alouche, Hélène Cannelle, Stéphanie Favre, et al.
International Journal of Laboratory Hematology|March 5, 2024
White blood cells scattergram as a valuable tool for COVID-19 screening: A multicentric studyJennifer Osman, Cécile Gonnin, Jérome Lambert, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2004
Any clinical benefit from the use of oncofoetal markers in the management of chemotherapy for patients with metastatic colorectal carcinomas?V Trillet-Lenoir, F Chapuis, S Touzet, et al.
Acta Neuropathologica|May 9, 2019
BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylationMaxime Sartori, Tiago Mendes, Shruti Desai, et al.
Frontiers in Veterinary Science|February 19, 2019
British Red Squirrels Remain the Only Known Wild Rodent Host for Leprosy BacilliAnna-Katarina Schilling, Charlotte Avanzi, Rainer G Ulrich, et al.
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trialAndrew J Cowan, Margot J Pont, Blythe D Sather, et al.
Pageof 163